Contact this trialFirst, we need to learn more about you.
IDH Mutant Targeted Therapy
IDH Mutant Targeted Therapies + Azacitidine for Acute Myeloid Leukemia
Recruiting1 awardPhase 1 & 2
Houston, Texas
This trial will study two drugs, AG-120 and AG-221, in combination with azacitidine, to see if they are safe and effective in treating AML with IDH1 or IDH2 mutations.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service